Fab'entech: Funding, Investors & Team (Sep 2026)
Fabentech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency. In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be prepared to address various situations of public health & medical emergency. However, there is generally no real therapeutic option to fight acute symptoms arising from these neglected indications. Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields of biodefense, drug intoxication and infectious disease. After having developed Fabenflu®, a product indicated for the treatment of avian influenza (H5N1) in human, Fab’entech is currently focusing on 3 products: a biodefense antidote developed in collaboration with the French army, a treatment for drug intoxication developed in a confidential indication, and an Ebola therapy developed with the support of the European Commission after having been identified by the WHO as the unique therapeutic solution in Europe in 2014.
Fab'entech has raised $21.9M across 1 funding round on record, the most recent an undisclosed round of $21.9M announced in Oct 2024.
That round is above the $7.3M median round size for Government and Military companies tracked on FundedIQ over the last two years.
Fab'entech Company Profile and Key Stats
Latest funding round on record: Oct 2024.
Fab'entech Funding Rounds
Fab'entech Founders and Leadership Team
Contact details for the Fab'entech team: 1 of 1 has an email address on file.
Start 14-day free trial →Fab'entech Funding Compared to Other Government and Military Startups
Fab'entech's latest round of $21.9M is above the median round in Government and Military. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Fab'entech in Government and Military and Lyon
Companies Similar to Fab'entech
SCorp-io develops SCADA and IoT offerings for civil infrastructure and industrial assets. The organization…
BatiFire offers a risk prevention service that facilitates the connection between buildings and security and…
The French industry pioneer for unmanned ground vehicles (UGVs) is Shark Robotics. Due to its expertise,…
Castelion is a startup company in the defense technology sector that is funded by investors. They are using…
Gecko Robotics offers robotics and inspection services for industrial purposes. Their integrated solutions…
Dominion Dynamics is a defense technology company that develops AI-native command, control, and intelligence…
Helicon Industries is a developer of advanced composite manufacturing systems for aerospace, defense, and…
Invisible Wounds Foundation is a non-profit organization advancing brain health care for military veterans.
Traysar engineers autonomous systems for the underground. Precise, expeditionary, self-guided, and built for…
Increasing the rate of American capability.
Zulu Pods offer an innovative advancement in propulsion technology with their unique oil-filled pod design,…
Mach Industries specializes in creating defense systems for unmanned aerial vehicles and missiles, as well as…
Fab'entech Funding FAQs
What does Fab'entech do?
Fabentech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency. In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be prepared to address various situations of public health & medical emergency. However, there is generally no real therapeutic option to fight acute symptoms arising from these neglected indications. Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields of biodefense, drug intoxication and infectious disease. After having developed Fabenflu®, a product indicated for the treatment of avian influenza (H5N1) in human, Fab’entech is currently focusing on 3 products: a biodefense antidote developed in collaboration with the French army, a treatment for drug intoxication developed in a confidential indication, and an Ebola therapy developed with the support of the European Commission after having been identified by the WHO as the unique therapeutic solution in Europe in 2014.
How much funding has Fab'entech raised?
Fab'entech has raised $21.9M across 1 round on record. The most recent is an undisclosed round of $21.9M announced in Oct 2024.
When did Fab'entech last raise funding?
Fab'entech's most recent funding round on record is an undisclosed round of $21.9M, announced in Oct 2024.
Who founded Fab'entech?
FundedIQ lists Bertrand Lepine (Founder) at Fab'entech.
Where is Fab'entech headquartered?
Fab'entech is based in Lyon, Rhone-Alpes, France.
How many employees does Fab'entech have?
Fab'entech is in the 11-50 employee band.
How does Fab'entech's funding compare to other Government and Military startups?
Fab'entech's latest round of $21.9M is above the $7.3M median round size for Government and Military companies on FundedIQ across 244 tracked companies over the last two years.
About FundedIQ's Fab'entech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Fab'entech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.